Can the Development of Orphan Drugs Include Wider Patient Engagement? A Citizens' Jury to Explore a Promissory Notion

Documents similaires

• Widening Patient Engagement for Rare Disease Drug Trials: The Perspectives of Patients With Idiopathic Pulmonary Fibrosis on Participating in Clinical Drug Trials and Drug Trial Design
  par: Julia Frost, et autres
  Publié: (2025)
• Assessing the Quality of Community Jury Deliberations in Online and In‐Person Community Juries Using a Deductive Coding Framework
  par: Hanan Abukmail, et autres
  Publié: (2025)
• Co‐Designing an Engagement Strategy to Include the Voices of a Minority Group in Assessing the Quality of Maternity and Neonatal Care
  par: Thérèse McDonnell, et autres
  Publié: (2025)
• Building Engagement‐Capable Environments for Health System Transformation: Development and Early Implementation of a Capability Framework for Patient, Family and Caregiver Engagement in Ontario Health Teams
  par: Julia Abelson, et autres
  Publié: (2024)
• Patient Engagement in Integrated Care: What Matters and Why?
  par: Marissa Bird, et autres
  Publié: (2025)